|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. QuickStats: Annual Rate of Visits* to Office-Based Physicians and Hospital Outpatient Departments During Which Combination Estrogen-Progestin Hormone Therapy Was Prescribed for Women Aged >40 years, by Age Group --- United States, 2001--2003
* Per 100 women in age group. From 2001 to 2003, the overall rate of visits to physicians during which combination estrogen-progestin hormone therapy was prescribed decreased by 44%. The decline was greatest among women aged >50 years. In July 2002, the National Institutes of Health terminated a clinical trial of combined hormone therapy (a component of the Women's Health Initiative) after investigators determined that the associated health risks outweighed the benefits. SOURCE: Hing E, Brett K. Changes in U.S. prescribing patterns of menopausal hormone replacement therapy, 2001--2003. Obstet Gynecol 2006;108:33--40.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 9/28/2006 |
|||||||||
|